SBRT radiation plus standard treatment for spread cancer
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must be confirmed as metastatic on scans and biopsy, not just suspected.
- You must have breast cancer or non-small cell lung cancer, and (for lung cancer) your gene test must fit the trial rules.
- Your cancer is either newly found as metastatic, or it has not worsened for at least 3 months on your current systemic treatment (based on imaging).
- You must have measurable tumors on scan, and no more than 5 separate targetable spots that can be treated with SBRT (with some rules for close-by spots).
- You must be able to have SBRT to the relevant targets safely, based on location and your nearby organ health.
- You must be age 18 or older and in generally good functional condition (ECOG 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
This trial tests whether giving radiation to a few growing spots (1-3) can let you stay on your current drug longer, instead of switching to a new one right away. It's for people with metastatic breast cancer whose disease has been stable for months but now shows limited progression.
This trial tests whether focused radiation (SBRT) can help control adenoid cystic carcinoma that has spread to a small number of places (oligometastatic disease). If you qualify, the study will treat up to 1–5 metastatic spots that doctors think can be safely targeted, to help control the cancer locally.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
Hear when a new Triple Negative Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.